Physician profile
Alan J Rechter
NPI 1497732739
$605,400.92
in general payments reported to CMS, 2019-2025
35 companies · $164K in 2025
The $164K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,594 · 2020: $7,134 · 2021: $149K · 2022: $134K · 2023: $20K · 2024: $126K · 2025: $164K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $222K · Travel and Lodging: $38K · Consulting Fee: $37K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $222,393.50 |
| Travel and Lodging | $37,618.99 |
| Consulting Fee | $37,264.50 |
| Food and Beverage | $13,444.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $556,585.67 | 2020-2025 | Zynrelef, Aponvie |
| Vertex Pharmaceuticals Incorporated | $21,247.12 | 2025 | |
| Stryker Corporation | $13,923.79 | 2019-2025 | Mako, Restoration, Insignia |
| Davol INC. | $4,764.50 | 2024-2025 | |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2021 | |
| Horizon Therapeutics Plc | $1,433.97 | 2019-2022 | |
| Medinc of Texas | $1,369.01 | 2022-2024 | |
| Globus Medical, INC. | $671.92 | 2020-2025 | Stelkast Generic Knee Instruments, Anthem, Mini Fragment System |
| Radius Health, INC. | $503.14 | 2019-2024 | Tymlos |
| Smith+Nephew, INC. | $357.29 | 2023-2025 | Real Intelligence, Journey II, Or3o Dual Mobility |
| Teva Pharmaceuticals USA, INC. | $239.56 | 2019 | |
| Amgen INC. | $226.23 | 2019-2025 | Evenity, Prolia |
| Si-Bone, INC. | $207.82 | 2019-2020 | |
| Depuy Synthes Sales INC. | $169.41 | 2019-2020 | |
| Alafair Biosciences, INC. | $160.53 | 2023-2024 | Versawrap |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $159.13 | 2019-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Xcell |
| Baudax Bio INC. | $158.73 | 2020-2021 | |
| Seaspine Orthopedics Corporation | $154.18 | 2019 | |
| Next Science LLC | $145.57 | 2025 | Blastx, Xperience |
| Treace Medical Concepts, INC. | $123.69 | 2023-2025 | |
| Nevro Corp. | $123.57 | 2019 | |
| Shoulder Innovations, INC. | $121.28 | 2024-2025 | Inset System |
| Ermi LLC | $95.47 | 2020-2025 | |
| Integra Lifesciences Corporation | $86.93 | 2019 | |
| Pfizer INC. | $65.08 | 2020-2021 | |
| Pacira Therapeutics, INC. | $62.38 | 2019-2021 | |
| Nalu Medical, INC. | $53.47 | 2025 | Nalu Neurostimulation System |
| Assertio Therapeutics, INC. | $39.43 | 2019 | |
| Zyla Life Sciences, INC. | $34.42 | 2019 | |
| Microport Orthopedics INC | $32.57 | 2025 | Mpo Medial Pivot Knee |
| Ossur Americas, INC. | $27.50 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $19.23 | 2021 | |
| Zimmer Biomet Holdings, INC. | $17.02 | 2019 | |
| Carbofix Orthopedics INC | $16.11 | 2023 | |
| Electronic Waveform Lab, INC. | $5.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Rechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.